Package 0074-2310-20

Brand: rinvoq

Generic: upadacitinib
NDC Package Sample

Package Facts

Identity

Package NDC 0074-2310-20
Digits Only 0074231020
Product NDC 0074-2310
Description

14 TABLET, EXTENDED RELEASE in 1 BOTTLE (0074-2310-20)

Marketing

Marketing Status
Marketed Since 2019-08-16
Brand rinvoq
Generic upadacitinib
Sample Package Yes

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "13f26758-52b4-4239-9981-a4b550e740e2", "openfda": {"nui": ["N0000190858", "N0000190857"], "unii": ["4RA0KN46E0"], "rxcui": ["2196894", "2196900", "2590051", "2590054", "2596957", "2596960", "2681015", "2681019"], "spl_set_id": ["2966aec7-2ef0-923c-d8ff-fe1a957bf095"], "pharm_class_epc": ["Janus Kinase Inhibitor [EPC]"], "pharm_class_moa": ["Janus Kinase Inhibitors [MoA]"], "manufacturer_name": ["AbbVie Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": true, "description": "14 TABLET, EXTENDED RELEASE in 1 BOTTLE (0074-2310-20)", "package_ndc": "0074-2310-20", "marketing_start_date": "20190816"}, {"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (0074-2310-30)", "package_ndc": "0074-2310-30", "marketing_start_date": "20190816"}], "brand_name": "Rinvoq", "product_id": "0074-2310_13f26758-52b4-4239-9981-a4b550e740e2", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Janus Kinase Inhibitor [EPC]", "Janus Kinase Inhibitors [MoA]"], "product_ndc": "0074-2310", "generic_name": "Upadacitinib", "labeler_name": "AbbVie Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Rinvoq", "active_ingredients": [{"name": "UPADACITINIB", "strength": "30 mg/1"}], "application_number": "NDA211675", "marketing_category": "NDA", "marketing_start_date": "20190816", "listing_expiration_date": "20261231"}